Prof. Haşmet Ayhan HANAĞASI

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology , vol.42, no.9, pp.3829-3834, 2021 (SCI-Expanded)

49. Dopamine Agonist-Associated Hiccup in Parkinson's Disease: A Case Report

Emekli A. S., HANAĞASI H. A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.58, no.3, pp.253-254, 2021 (SCI-Expanded) Sustainable Development

50. A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease

Fevga C., Park Y., Lohmann E., Kievit A. J., Breedveld G. J., Ferraro F., et al.

MOVEMENT DISORDERS , vol.36, 2021 (SCI-Expanded)

51. Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (Canvas) is an important cause of late-onset ataxia

Cakar A., Sahin E., Tezel S., Candayan A., Samanci B., BATTALOĞLU E., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.26, no.3, pp.364, 2021 (SCI-Expanded)

52. A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease.

Fevga C., Park Y., Lohmann E., Kievit A. J., Breedveld G. J., Ferraro F., et al.

Parkinsonism & related disorders , vol.89, pp.63-72, 2021 (SCI-Expanded)

53. TREM2 variants as a possible cause of frontotemporal dementia with distinct neuroimaging features

Samanci B., Bilgiç B., Gelişin Ö., Tepgeç F., Guven G., Tüfekçioğlu Z., et al.

EUROPEAN JOURNAL OF NEUROLOGY , vol.28, no.8, pp.2603-2613, 2021 (SCI-Expanded, Scopus)

54. A novel SACS p.Pro4154GlnfsTer20 mutation in a family with autosomal recessive spastic ataxia of Charlevoix-Saguenay

SAMANCI B., Gokalp E. E., BİLGİÇ B., Gurvit H., ARTAN S., HANAĞASI H. A.

NEUROLOGICAL SCIENCES , vol.42, no.7, pp.2969-2973, 2021 (SCI-Expanded)

55. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.

MOVEMENT DISORDERS , vol.36, pp.1676-1688, 2021 (SCI-Expanded)

56. The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias.

Traschuetz A., Reich S., Adarmes A. D., Anheim M., Ashrafi M. R., Baets J., et al.

Frontiers in neurology , vol.12, pp.677551, 2021 (SCI-Expanded) Sustainable Development

57. Piribedil-induced Reversible Pisa Syndrome in a Patient with Lewy Body Dementia

Atmaca M. M., Bilgic B., Hanagasi H.

TURKISH JOURNAL OF NEUROLOGY , vol.27, no.2, pp.192-194, 2021 (ESCI)

58. A novel PSEN2 p.Ser175Phe variant in a family with Alzheimer's disease

Guven G., Samancı B., Güleç Ç., Hanagasi H., Gürvit İ. H., Gokalp E. E., et al.

NEUROLOGICAL SCIENCES , vol.42, no.6, pp.2497-2504, 2021 (SCI-Expanded, Scopus)

59. Biallelic variants in TSPOAP1, encoding the active-zone protein RIMBP1, cause autosomal recessive dystonia

Mencacci N. E., Brockmann M. M., Dai J., Pajusalu S., Atasu B., Campos J., et al.

JOURNAL OF CLINICAL INVESTIGATION , vol.131, no.7, 2021 (SCI-Expanded)

60. A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia

Emekli A. S., Samanci B., Simsir G., Hanagasi H. A., Gurvit H., Bilgic B., et al.

NEUROLOGICAL SCIENCES , no.4, pp.1535-1539, 2021 (SCI-Expanded) Sustainable Development

61. PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice.

Messerschmidt C., Foddis M., Blumenau S., Müller S., Bentele K., Holtgrewe M., et al.

Scientific reports , vol.11, no.1, pp.6072, 2021 (SCI-Expanded, Scopus)

62. Psychometric Properties of Turkish Version of Survey of Activities and Fear of Falling in the Elderly Among Patients with Parkinson's Disease

Tufekcioglu Z., Huseyinsioglu B. E., Bilgic B., Hanagasi H. A.

TURKISH JOURNAL OF NEUROLOGY , vol.27, no.1, pp.46-51, 2021 (ESCI)

63. Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients.

Karaaslan Z., Kahraman Ö. T., Şanlı E., Ergen H. A., Ulusoy C., Bilgiç B., et al.

Scientific reports , vol.11, no.1, pp.2316, 2021 (SCI-Expanded) Sustainable Development

64. Functional Connectivity Analysis in Heterozygous Glucocerebrosidase Mutation Carriers

Sezgin M., Kicik A., Bilgic B., Kurt E., Bayram A., Hanagası H. A., et al.

JOURNAL OF PARKINSONS DISEASE , vol.11, no.2, pp.559-568, 2021 (SCI-Expanded)

65. EXPRESSION OF SELECTED miRNAs IN CIRCULATING BLOOD OF EARLY AND LATE-ONSET ALZHEIMER DISEASE PATIENTS

guven g., Lohmann E., Gulec C., bilgic b., ÖZER TOPALOĞLU E., Hanagasi H., et al.

İstanbul Tıp Fakültesi Dergisi , vol.84, no.2, pp.165-174, 2021 (ESCI, Scopus, TRDizin)

66. **COMBINED ANALYSIS OF LINKAGE AND WHOLE EXOME SEQUENCING REVEALS CIC AS A CANDIDATE GENE FOR ISOLATED DYSTONIA**

Salman B., YÜCESAN E., SAMANCI B., BİLGİÇ B., HANAĞASI H. A., Gurvit I., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.84, no.4, pp.457-463, 2021 (ESCI)

67. Cognition of the mothers of patients with Duchenne muscular dystrophy.

Demirci H., Durmus H., Toksoy G., Uslu A., Parman Y., Hanagasi H. A.

Muscle & nerve , vol.62, no.6, pp.710-716, 2020 (SCI-Expanded, Scopus)

68. Characterization of Recessive Parkinson Disease in a Large Multicenter Study

Lesage S., Lunati A., Houot M., Ben Romdhan S., Clot F., Tesson C., et al.

ANNALS OF NEUROLOGY , vol.88, no.4, pp.843-850, 2020 (SCI-Expanded)

69. The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Arslan D. B., Gurvit H., Genc O., Kicik A., Eryurek K., Cengiz S., et al.

Journal of neural transmission (Vienna, Austria : 1996) , vol.127, pp.1285-1294, 2020 (SCI-Expanded)

70. Caregiver Burden, Quality of Life and Related Factors in Family Caregivers of Dementia Patients in Turkey.

Tulek Z., Baykal D., Erturk S., Bilgic B., Hanagasi H. A., Gurvit İ. H.

Issues in mental health nursing , vol.41, no.8, pp.741-749, 2020 (SCI-Expanded)

71. Peripheral TREM2 mRNA levels in early and late-onset Alzheimer disease's patients.

Guven G., BİLGİÇ B., SAMANCI B., GÜRVİT İ. H., Hanagasi H. A., Donmez C., et al.

Molecular biology reports , vol.47, no.8, pp.5903-5909, 2020 (SCI-Expanded, Scopus)

72. Clinico-Genetic, Imaging and Molecular Delineation of COQ8A-Ataxia: A Multicenter Study of 59 Patients

Traschuetz A., Schirinzi T., Laugwitz L., Murray N. H., Bingman C. A., Reich S., et al.

ANNALS OF NEUROLOGY , vol.88, no.2, pp.251-263, 2020 (SCI-Expanded)

73. Revisiting the complex architecture of ALS in Turkey: Expanding genotypes, shared phenotypes, molecular networks, and a public variant database

Tunca C., Seker T., Akcimen F., Coskun C., Bayraktar E., Palvadeau R., et al.

HUMAN MUTATION , vol.41, no.8, 2020 (SCI-Expanded)

74. The association of serum clusterin levels and Clusterin rs11136000 polymorphisms with Alzheimer disease in a Turkish cohort

Guven G., Ozer E., Bilgiç B., Hanagasi H., Gurvit H., Lohmann E., et al.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , vol.37, no.3, pp.134-141, 2020 (SCI-Expanded)

75. Event-related potential changes due to early-onset Parkinson's disease in parkin (PARK2) gene mutation carriers and non-carriers

USLU A., ERGEN M., Demirci H., Lohmann E., Hanagasi H., DEMİRALP T.

CLINICAL NEUROPHYSIOLOGY , vol.131, no.7, pp.1444-1452, 2020 (SCI-Expanded)

76. Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START

Bahat G., Ilhan B., Erdogan T., Halil M., Savas S., Ulger Z., et al.

EUROPEAN GERIATRIC MEDICINE , vol.11, no.3, pp.491-498, 2020 (SCI-Expanded, Scopus) Sustainable Development

77. Small ubiquitin-related modifier (SUMO) 3 and SUMO4 gene polymorphisms in Parkinson's disease

Küçükali C. İ., Salman B., Yüceer H., Ulusoy C. A., Abacı N., Ekmekci S., et al.

NEUROLOGICAL RESEARCH , vol.42, no.6, pp.451-457, 2020 (SCI-Expanded) Sustainable Development

78. Multicenter study of levodopa carbidopa intestinal gel in Parkinson's disease: the Turkish experience

GÜLTEKİN M., Ulukan Ç., Tezcan S., Doğu O., Hanağasi H. A., BİLGİÇ B., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.1, pp.66-85, 2020 (SCI-Expanded)

79. A patient with early-onset Alzheimer's disease with a novel PSEN1 p.Leu424Pro mutation

Guven G., Erginel-Unaltuna N., Samanci B., Gulec C., Hanagasi H. A., Bilgic B.

NEUROBIOLOGY OF AGING , vol.84, 2019 (SCI-Expanded, Scopus)

80. Late-onset phenotype associated with a homozygous GJC2 missense mutation in a Turkish family

Kuipers D., Tufekcioglu Z., Bilgiç B., Olgiati S., Dremmen M., van I., et al.

PARKINSONISM & RELATED DISORDERS , vol.66, pp.228-231, 2019 (SCI-Expanded)

81. Using global team science to identify genetic parkinson's disease worldwide

Vollstedt E., Kasten M., Klein C.

ANNALS OF NEUROLOGY , vol.86, no.2, pp.153-157, 2019 (SCI-Expanded)

82. Neuroinflammation Mediators are Reduced in Sera of Parkinson's Disease Patients with Mild Cognitive Impairment.

Kıçık A., Tüzün E., Erdoğdu E., Bılgıç B., Tüfekçıoğlu Z., Öztürk-Işik E., et al.

Noro psikiyatri arsivi , vol.57, pp.15-17, 2019 (SCI-Expanded)

83. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort

Guven G., Vurgun E., Bilgic B., Hanagası H. A., Gurvit H., Özer E., et al.

MOLECULAR BIOLOGY REPORTS , vol.46, no.2, pp.1701-1707, 2019 (SCI-Expanded, Scopus)

84. Amyloid Beta Adsorption Problem with Transfer Plates in Amyloid Beta 1-42 IVD Kits

Dursun E., Alaylıoğlu M., Bilgiç B., Hanağası H. A., Gürvit H., Emre M., et al.

JOURNAL OF MOLECULAR NEUROSCIENCE , vol.67, no.4, pp.534-539, 2019 (SCI-Expanded)

85. Patients with Lately Diagnosed Cerebrotendinous Xanthomatosis.

Yunisova G., Tufekcioglu Z., DOĞU O., Bilgic B., Kaleagasi H., Akca Kalem S., et al.

Neuro-degenerative diseases , vol.19, no.5-6, pp.218-224, 2019 (SCI-Expanded) Sustainable Development

86. Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia

Guven G., Bilgic B., Tufekcioglu Z., Unaltuna N., Hanagasi H. A., Gurvit H., et al.

JOURNAL OF ALZHEIMERS DISEASE , vol.67, no.1, pp.159-167, 2019 (SCI-Expanded, Scopus)

87. Olfactory function and olfactory bulb volume in Wilson's disease

DEĞİRMENCİ N., Veyseller B., Hanagasi H. A., Bilgic B., Gurbuz D., TOPRAK A., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.276, no.1, pp.139-142, 2019 (SCI-Expanded)

88. Which cognitive dual-task walking causes most interference on the Timed Up and Go test in Parkinson's disease: a controlled study.

ZIREK E., Ersoz H., TUFEKCIOGLU Z., Bilgic B., HANAGASI H. A.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology , vol.39, pp.2151-2157, 2018 (SCI-Expanded)

89. HPCA Confirmed as a Genetic Cause of DYT2-Like Dystonia Phenotype

Atasu B., Hanagasi H. A., Bilgic B., Pak M., Erginel-Unaltuna N., Hauser A., et al.

MOVEMENT DISORDERS , vol.33, no.8, pp.1354-1358, 2018 (SCI-Expanded, Scopus)

90. Use of anti-Parkinson medication during pregnancy: a case series

Tufekcioglu Z., Hanagasi H. A., YALÇIN ÇAKMAKLI G., ELİBOL B., Tokucoglu F. E., Kaya Z. E., et al.

JOURNAL OF NEUROLOGY , vol.265, no.8, pp.1922-1929, 2018 (SCI-Expanded)

91. Clinical phenotype of hereditary spastic paraplegia due to KIF1C gene mutations across life span.

Yucel-Yilmaz D., Yucesan E., YALNIZOĞLU D., Oguz K. K., SAGIROGLU M. S., Ozbek U., et al.

Brain & development , vol.40, no.6, pp.458-464, 2018 (SCI-Expanded)

92. Nasu Hakola Disease: A Rare Cause of Dementia and Cystic Bone Lesions, Report of a New Turkish Family

Koseoglu E., Tepgec F., YETKİN M. F., Uyguner O., Ekinci A., ABDÜLREZZAK Ü., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.55, no.1, pp.98-102, 2018 (SCI-Expanded)

93. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey

KESSLER C., ATASU B., Hanagasi H. A., SIMON-SANCHEZ J., HAUSER A., Pak M., et al.

PARKINSONISM & RELATED DISORDERS , vol.48, pp.34-39, 2018 (SCI-Expanded)

94. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale

AKBOSTANCI M. C., Bayram E., Yilmaz V., Rzayev S., ÖZKAN S., Tokcaer A. B., et al.

MOVEMENT DISORDERS CLINICAL PRACTICE , vol.5, no.1, pp.54-59, 2018 (ESCI)

95. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease

Uysal-Canturk P., Hanagasi H. A., Bilgic B., Gurvit H., Emre M.

EUROPEAN JOURNAL OF NEUROLOGY , vol.25, no.1, pp.148-153, 2018 (SCI-Expanded)

96. SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey

Yucesan E., UĞUR İŞERİ S. A., Bilgic B., Gormez Z., Bakir Gungor B., Sarac A., et al.

NEUROLOGICAL SCIENCES , vol.38, no.12, pp.2203-2207, 2017 (SCI-Expanded)

97. Mutations in TYROBP are not a common cause of dementia in a Turkish cohort

Darwent L., Carmona S., Lohmann E., GUVEN G., Kun-Rodrigues C., Bilgic B., et al.

Neurobiology of Aging , vol.58, 2017 (SCI-Expanded, Scopus)

98. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN.

OLGIATI S., DOĞU O., TUFEKCIOGLU Z., DILER Y., SAKA E., GULTEKIN M. H., et al.

Parkinsonism & related disorders , vol.39, pp.64-70, 2017 (SCI-Expanded)

99. Dementia in Parkinson's disease

Hanagasi H. A., Tufekcioglu Z., Emre M.

JOURNAL OF THE NEUROLOGICAL SCIENCES , vol.374, pp.26-31, 2017 (SCI-Expanded)

100. GC and VDR SNPs and Vitamin D Levels in Parkinson's Disease: The Relevance to Clinical Features

Gezen-Ak D., Alaylioglu M., GENC G., Gunduz A., Candas E., Bilgic B., et al.

NEUROMOLECULAR MEDICINE , vol.19, no.1, pp.24-40, 2017 (SCI-Expanded)

101. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey

AKÇAKAYA N., Iseri S. A., BILIR B., BATTALOGLU E., TEKTURK P., GULTEKIN M. H., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , pp.34-42, 2017 (SCI-Expanded) Sustainable Development

102. Impact of Neuro-Behcet Disease Immunoglobulin G on Neuronal Apoptosis

Giris M., Bireller S., Kucukali C. I., Hanagasi H. A., Degirmencioglu S., Tuzun E.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.54, no.1, pp.67-71, 2017 (SCI-Expanded)

103. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease

Senturk G., Bilgic B., Arslan A. B., Bayram A., Hanagasi H. A., Gurvit H., et al.

International Psychogeriatrics , vol.29, no.2, pp.293-302, 2017 (SCI-Expanded)

104. ARE THE NEUROPSYCHOLOGICAL PROFILES OF TEMPORAL LOBE EPILEPSY PATIENTS WITH NEURONAL AUTO-ANTIBODIES DIFFERENT?

Sezgin M., Yavuz V. E. N., Bilgic B., Tuzun E., Hanagasi H. A., Bebek N., et al.

EPILEPSIA , vol.57, pp.139-140, 2016 (SCI-Expanded)

105. Analysis of the tremor in juvenile myoclonic epilepsy

Aydin-Ozemir Z., Matur Z., Baykan B., Bilgic B., Tekturk P., Bebek N., et al.

EPILEPSY RESEARCH , pp.140-148, 2016 (SCI-Expanded) Sustainable Development

106. Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia

Lynch D. S., Zhang W. J., Lakshmanan R., Kinsella J. A., Uzun G. A., Karbay M., et al.

JAMA NEUROLOGY , vol.73, no.12, pp.1433-1439, 2016 (SCI-Expanded)

107. NMDA receptor encephalitis with cancer of unknown primary origin

Çoban A., GÜNDOGDU G., Poyraz M., Yegen G., DEMIRTAŞ-TATLIDEDE A., Bilgiç B., et al.

TUMORI , vol.102, 2016 (SCI-Expanded) Sustainable Development

108. Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer’s disease patients

Dursun E., Alaylioglu M., Bilgic B., Hanagasi H. A., Lohmann E., Atasoy I. L., et al.

Neurological Sciences , vol.37, no.10, pp.1633-1643, 2016 (SCI-Expanded)

109. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients

Guven G., Lohmann E., Bras J., GIBBS J. R., Gurvit H., Bilgic B., et al.

PLOS ONE , vol.11, no.9, 2016 (SCI-Expanded, Scopus)

110. A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family

Hanagasi H. A., Giri A., Kartal E., Guven G., Bilgic B., Hauser A., et al.

PARKINSONISM & RELATED DISORDERS , vol.29, pp.117-120, 2016 (SCI-Expanded, Scopus)

111. The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort

Alaylioglu M., Gezen-Ak D., Dursun E., Bilgic B., Hanagasi H. A., Ertan T., et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY , vol.29, no.4, pp.221-226, 2016 (SCI-Expanded)

112. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease

Tuzun E., Yalcinkaya N., Haytural H., Turkoglu R., Bilgic B., Hanagasi H. A., et al.

EUROPEAN JOURNAL OF NEUROLOGY , pp.839, 2016 (SCI-Expanded)

113. Further evidence that mutations in AARS2 cause an adult onset leukodystrophy

Lynch D., Zhang W. J., Lakshmanan R., Phadke R., Davagnanam I., Hanagasi H. A., et al.

EUROPEAN JOURNAL OF NEUROLOGY , vol.23, pp.698, 2016 (SCI-Expanded)

114. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism

Tufekcioglu Z., Cakar A., Bilgic B., Hanagasi H. A., Gurvit H., Emre M.

NEUROCASE , vol.22, no.3, pp.273-275, 2016 (SCI-Expanded) Sustainable Development

115. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease

Yalcinkaya N., Haytural H., Bilgic B., Ozdemir O., Hanagasi H. A., Kucukali C. I., et al.

NEUROSCIENCE LETTERS , vol.615, pp.72-77, 2016 (SCI-Expanded)

116. DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease

Olgiati S., Quadri M., Fang M., Rood J. P. M. A., Saute J. A., Chien H. F., et al.

ANNALS OF NEUROLOGY , vol.79, no.2, pp.244-256, 2016 (SCI-Expanded)

117. PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism

Giri A., Guven G., Hanagasi H. A., Hauser A., Erginul-Unaltuna N., Bilgic B., et al.

TREMOR AND OTHER HYPERKINETIC MOVEMENTS , vol.6, 2016 (ESCI, Scopus)

118. The Investigation of ANG-2 and PDGF-BB Genotyping in Alzheimer Disease

Pala M., Gurvit I. H., Hanagasi H. A., Lohmann E., Emre M., Unaltuna N. E.

ACTA PHYSIOLOGICA , vol.215, pp.20, 2015 (SCI-Expanded)

119. Clinical variability in ataxia-telangiectasia

LOHMANN E., KRUEGER S., HAUSER A., Hanagasi H. A., Guven G., Erginel-Unaltuna N., et al.

JOURNAL OF NEUROLOGY , vol.262, no.7, pp.1724-1727, 2015 (SCI-Expanded, Scopus)

120. A new F-box protein 7 gene mutation causing typical Parkinson's disease

Lohmann E., COQUEL A., HONORE A., Gurvit H., Hanagasi H. A., Emre M., et al.

MOVEMENT DISORDERS , vol.30, no.8, pp.1130-1133, 2015 (SCI-Expanded, Scopus)

121. Neuro-Behcet's Disease with Chorea

Gur Ozmen S., Hanagasi H. A., Gurvit H., Emre M., Akman Demir G.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.52, no.2, pp.200-201, 2015 (SCI-Expanded)

122. The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

HANAĞASI H. A.

MOVEMENT DISORDERS , vol.30, no.7, pp.1009, 2015 (SCI-Expanded)

123. Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation

Hanagasi H. A., Bilgic B., Abbink T. E. M., HANAGASI F., Tufekcioglu Z., Gurvit H., et al.

PARKINSONISM & RELATED DISORDERS , vol.21, no.5, pp.544-546, 2015 (SCI-Expanded)

124. The distinct genetic pattern of ALS in Turkey and novel mutations

Ozoguz A., Uyan O., Birdal G., Iskender C., Kartal E., Lahut S., et al.

Neurobiology of Aging , vol.36, no.4, 2015 (SCI-Expanded)

125. Prevalence of Parkinson's disease in Baskale, Turkey: a population based study

Durmus H., Gökalp M. A., Hanagasi H. A.

NEUROLOGICAL SCIENCES , vol.36, no.3, pp.411-413, 2015 (SCI-Expanded)

126. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Dursun E., Gezen-Ak D., Hanagasi H. A., Bilgic B., Lohmann E., Ertan S., et al.

Journal of Neuroimmunology , vol.283, pp.50-57, 2015 (SCI-Expanded)

127. FBX07-R498X mutation: Phenotypic variability from chorea to early onset parkinsonism within a family

Gunduz A., Eken A. G., Bilgic B., Hanagasi H. A., Bilguvar K., Guenel M., et al.

PARKINSONISM & RELATED DISORDERS , vol.20, no.11, pp.1253-1256, 2014 (SCI-Expanded)

128. Efficiency of Repeated Botulinum Toxin Type-A Injections in Post-Stroke Distal Limb Spasticity

Coban A., Matur Z., Hanagasi H. A., Parman Y.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , vol.31, no.1, pp.21-27, 2014 (SCI-Expanded)

129. Evaluation of incidence and clinical features of antibody-Associated autoimmune encephalitis mimicking dementia

Coban A., Kucukali C. I., Bilgic B., Yalcinkaya N., Haytural H., Ulusoy C., et al.

Behavioural Neurology , vol.2014, 2014 (SCI-Expanded)

130. Supranuclear Gaze Abnormality in Sporadic-Creutzfeldt Jacob Disease

Gur Ozmen S., Gurvit H., Hanagasi H. A., Alpsan Gokmen M. H., Emre M.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.51, no.1, pp.91-92, 2014 (SCI-Expanded)

131. A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family

Guerreiro R., Bilgic B., Guven G., Bras J., Rohrer J., Lohmann E., et al.

NEUROBIOLOGY OF AGING , vol.34, no.12, 2013 (SCI-Expanded, Scopus)

132. Silent neurological involvement in biopsy-defined coeliac patients

Bilgic B., Aygun D., Arslan A. B., BAYRAM A., Akyuz F., Sencer S., et al.

NEUROLOGICAL SCIENCES , vol.34, no.12, pp.2199-2204, 2013 (SCI-Expanded)

133. Orolingual Dyskinesia and Involuntary Neck Movements Caused by Phenytoin Intoxication

Gunduz T., Kocasoy-Orhan E., Hanagasi H. A.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.25, no.4, 2013 (SCI-Expanded)

134. Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance

Coban A., Bilgic B., Lohmann E., Kucukali C. I., Benbir G., Karadeniz D., et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS , vol.28, no.6, pp.606-611, 2013 (SCI-Expanded)

135. Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism

Quadri M., Fang M., Picillo M., Olgiati S., Breedveld G. J., Graafland J., et al.

HUMAN MUTATION , vol.34, no.9, pp.1208-1215, 2013 (SCI-Expanded) Sustainable Development

136. Pure gait disturbance displayed by malingerers: Case report of two patients

Benbir G., Hanagasi F., Ertan S., Hanagasi H. A., Ertan T.

CLINICAL NEUROLOGY AND NEUROSURGERY , vol.115, no.7, pp.1177-1179, 2013 (SCI-Expanded)

137. Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody

Cikrikcili U., Ulusoy C. A., Turan S., Yildiz S., Bilgic B., Hanagasi H. A., et al.

CLINICAL EEG AND NEUROSCIENCE , vol.44, no.3, pp.232-236, 2013 (SCI-Expanded)

138. MDS-UPDRS dopamine dysregulation syndrome scores correlate with Iowa gambling test performance

Gurvit H., Pulur N., Tatlidede A. D., Yildirim E., Bilgic B., Cakmur R., et al.

MOVEMENT DISORDERS , vol.28, 2013 (SCI-Expanded)

139. FBXO7 mutation: Phenotypic variability from chorea to early-onset asymmetric parkinsonism within a family

Gunduz A., Eken A. G., Bilguvar K., Gunel M., Basak A. N., Hanagasi H. A., et al.

MOVEMENT DISORDERS , vol.28, 2013 (SCI-Expanded)

140. Improvement under donepezil treatment in a patient with pure akinesia with freezing of gait

Topcular B., Yabalak A., Kaymaz A., Altinkaya A., Topcular N. S., Altunrende B., et al.

MOVEMENT DISORDERS , vol.28, 2013 (SCI-Expanded)

141. Prevalence of Parkinson's disease in Baskale, Turkey: A population-based study

Durmus H., Gokalp M. A., Hanagasi H. A.

MOVEMENT DISORDERS , vol.28, 2013 (SCI-Expanded)

142. BDNF, TNF alpha, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment

Gezen-Ak D., Dursun E., Hanagasi H. A., Bilgic B., Lohman E., Araz O. S., et al.

JOURNAL OF ALZHEIMERS DISEASE , vol.37, no.1, pp.185-195, 2013 (SCI-Expanded)

143. The Relationship of White Matter Hyperintensities with Depressive Symptoms and Daily Living Activities in Early-Stage Alzheimer's Disease Patients

Bilgic B., Bayram A., Hanagasi H. A., Tumac A., Uysal P., Senturk G., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.50, no.4, pp.360-363, 2013 (SCI-Expanded)

144. TREM2 Variants in Alzheimer's Disease

Guerreiro R., WOJTAS A., BRAS J., CARRASQUILLO M., Rogaeva E., MAJOUNIE E., et al.

NEW ENGLAND JOURNAL OF MEDICINE , vol.368, no.2, pp.117-127, 2013 (SCI-Expanded)

145. The ABC of Ataxia Should Also Include the E

Hanagasi H. A., Emre M.

MOVEMENT DISORDERS: UNFORGETTABLE CASES AND LESSONS FROM THE BEDSIDE , pp.238-239, 2013 (SCI-Expanded)

146. Parkinson's disease dementia

Bilgic B., Hanagasi H. A., Emre M.

NEUROPSYCHIATRIC AND COGNITIVE CHANGES IN PARKINSON'S DISEASE AND RELATED MOVEMENT DISORDERS: DIAGNOSIS AND MANAGEMENT , pp.177-191, 2013 (SCI-Expanded)

147. Chorea-Ballismus Associated with Hyperglycemia

Kocasoy Orhan E., Atmaca M. M., ATMACA M., Hanagasi H. A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.50, no.4, pp.375-378, 2013 (SCI-Expanded) Sustainable Development

148. Neuroimaging, biomarkers, and management of dementia with Lewy bodies

Hanagasi H. A., Bilgic B., Emre M.

FRONTIERS IN NEUROLOGY , vol.4, 2013 (SCI-Expanded)

149. Multiple System Atrophy (MSA-C) Presenting with Cognitive Affective Cerebellar Syndrome and Psychosis

Tatlidede A. D., Hanagasi H. A., Cabalar M., Yayla V.

TURKISH JOURNAL OF NEUROLOGY , vol.19, no.3, pp.107-110, 2013 (ESCI)

150. Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement

GUERREIRO R. J., Lohmann E., BRAS J. M., GIBBS J. R., Rohrer J. D., Gurunlian N., et al.

JAMA NEUROLOGY , vol.70, no.1, pp.78-84, 2013 (SCI-Expanded)

151. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease

Gezen-Ak D., Dursun E., Bilgic B., Hanagasi H. A., Ertan T., Gurvit H., et al.

Tohoku Journal of Experimental Medicine , vol.228, no.3, pp.189-196, 2012 (SCI-Expanded) Sustainable Development

152. Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients

Lohmann E., Guerreiro R. J., Erginel-Unaltuna N., Gurunlian N., Bilgic B., Gurvit H., et al.

NEUROBIOLOGY OF AGING , vol.33, no.8, 2012 (SCI-Expanded)

153. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: Contribution of automated segmentation neuroimaging method

Bilgic B., BAYRAM A., Arsian A. B., Hanagasi H. A., Dursun B., Gurvit H., et al.

PARKINSONISM & RELATED DISORDERS , vol.18, no.5, pp.562-566, 2012 (SCI-Expanded)

154. Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population

Lohmann E., Dursun B., LESAGE S., Hanagasi H. A., Sevinc G., HONORE A., et al.

EUROPEAN JOURNAL OF NEUROLOGY , vol.19, no.5, pp.769-775, 2012 (SCI-Expanded)

155. Dementia and behavioral neurology: recent advances

Bilgic B., Hanagasi H. A., Emre M.

JOURNAL OF NEUROLOGY , vol.259, no.5, pp.1006-1010, 2012 (SCI-Expanded)

156. The Impact of Familial Structure on Parkinson's Disease in Istanbul Medical School, Turkey

Lohmann E., Hanagasi H. A., Gurvit H., Kayaci G., Ruberg M., Yazici J., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.122, no.2, pp.102-105, 2012 (SCI-Expanded)

157. A homozygous frameshift mutation of sepiapterin reductase gene causing parkinsonism with onset in childhood

Lohmann E., Koroglu C., Hanagasi H. A., Dursun B., Tasan E., TOLUN A.

PARKINSONISM & RELATED DISORDERS , vol.18, no.2, pp.191-193, 2012 (SCI-Expanded)

158. A rare dementing disease: Adult neuronal ceroid lipofuscinoses

Babacan-Yildiz G., Hanagasi H. A., Gurvit H., Sirin G., Solakoglu S., KÜÇÜK Ö. S.

Journal of Neuropsychiatry and Clinical Neurosciences , vol.24, no.4, pp.493-498, 2012 (SCI-Expanded)

159. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease

Guerreiro R. J., Lohmann E., KINSELLA E., Bras J. M., LUU N., Gurunlian N., et al.

Neurobiology of Aging , vol.33, no.5, 2012 (SCI-Expanded)

160. LRRK2 mutations are uncommon in Turkey

Hanagasi H. A., Lohmann E., Dursun B., HONORE A., LESAGE S., Dogu O., et al.

European Journal of Neurology , vol.18, no.10, 2011 (SCI-Expanded)

161. The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Hanagasi H. A., Gurvit H., Unsalan P., Horozoglu H., Tuncer N., Feyzioglu A., et al.

MOVEMENT DISORDERS , vol.26, no.10, pp.1851-1858, 2011 (SCI-Expanded)

162. Erdheim Chester disease presenting as slowly progressive cerebellar syndrome and asymptomatic widespread skeletal involvement

Tufan F., Myftiu B., Aygun D., Keles N., Haroche J., Hanagasi H. A., et al.

EUROPEAN JOURNAL OF NEUROLOGY , vol.18, no.8, 2011 (SCI-Expanded)

163. Pain is common in Parkinson's disease

HANAGASI H. A., AKAT S., Gurvit H., Yazici J., Emre M.

CLINICAL NEUROLOGY AND NEUROSURGERY , vol.113, no.1, pp.11-13, 2011 (SCI-Expanded)

164. Unilateral Ablative Lesions of the Subthalamic Nucleus in Moderate-to-Advanced Parkinson's Disease

Hanagasi H. A., Barlas O.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.48, no.2, pp.114-118, 2011 (SCI-Expanded)

165. An Unusual Late Presentation of Subacute Sclerosing Panencephalitis With Psychotic Symptoms

Baran Z., Hanagasi H. A., Ucok A.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.22, no.1, 2010 (SCI-Expanded)

166. Early-Onset L-dopa-Responsive Parkinsonism with Pyramidal Signs Due to ATP13A2, PLA2G6, FBXO7 and Spatacsin Mutations

Paisan-Ruiz C., Guevara R., Federoff M., Hanagasi H. A., Sina F., Elahi E., et al.

MOVEMENT DISORDERS , vol.25, no.12, pp.1791-1800, 2010 (SCI-Expanded)

167. TP53 R72P POLYMORPHISM AS A MODIFIER OF AGE AT ONSET OF HUNTINGTON'S DISEASE

Tunali N. E., Acar-Hazer A., Erginel-Unaltuna N., Hanagasi H. A.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , vol.81, 2010 (SCI-Expanded)

168. THE EFFECTS OF GRIN GENE VARIATIONS ON AGE AT ONSET OF TURKISH HUNTINGTON'S DISEASE PATIENTS

Tunali N. E., Acar-Hazer A., Erginel-Unaltuna N., Hanagasi H. A.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , vol.81, 2010 (SCI-Expanded)

169. Iatrogenic Botulism After Botulinum Toxin Type A Injections

Coban A., Matur Z., Hanagasi H. A., Parman Y.

CLINICAL NEUROPHARMACOLOGY , vol.33, no.3, pp.158-160, 2010 (SCI-Expanded)

170. Hypersecretory Disorders and Botulinum Toxin

Hanagasi H. A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.47, pp.48-51, 2010 (SCI-Expanded)

171. Long-Term Effects Of Olanzapine in Various Movement Disorders

Coban A., Hanagasi H. A.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.47, no.3, pp.213-215, 2010 (SCI-Expanded)

172. Differences between essential tremor developing Parkinson's disease and essential tremor Parkinson hastalıǧı gelişltiren esansiyel tremor ile esansiyel tremor arasındaki farklılıklar

Yildiz G. B., Coban A., Hanagasi H. A., Gurvit H., Yazici J.

Noropsikiyatri Arsivi , vol.47, no.2, pp.101-104, 2010 (SCI-Expanded)

173. The combinations of TNF alpha-308 and IL-6-174 or IL-10-1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease

Vural P., Degirmencioglu S., Parildar-Karpuzoglu H., Dogru-Abbasoglu S., Hanagasi H. A., Karadag B., et al.

ACTA NEUROLOGICA SCANDINAVICA , no.6, pp.396-401, 2009 (SCI-Expanded)

174. Clinical and electrophysiological investigations of changes in muscle activation patterns before and after botulinum toxin injections for idiopathic cervical dystonia Idyopatik servikal distonili hastalarda botulinum toksini uygulanmasιndan önce ve sonra kas aktivasyon paterninde görülen deǧişimlerin incelenmesi

Kocaman G., Baris M. B., Hanagasi H. A., Parman Y. G.

Noropsikiyatri Arsivi , vol.46, no.2, pp.39-43, 2009 (SCI-Expanded)

175. Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease

Coban A., Hanagasi H. A., Karamursel S., Barlas O.

BRITISH JOURNAL OF NEUROSURGERY , no.1, pp.23-29, 2009 (SCI-Expanded) Sustainable Development

176. MITOCHONDRIAL PATHOLOGY IN MUSCLE OF A PATIENT WITH A NOVEL PARKIN MUTATION

Hanagasi H. A., Serdaroglu P., Ozansoy M., Basak N., Tasli H., Emre M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.119, no.10, pp.1572-1583, 2009 (SCI-Expanded)

177. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease

Parildar-Karpuzoglu H., Dogru-Abbasoglu S., Hanagasi H. A., Karadag B., Gurvit H., Emre M., et al.

NEUROSCIENCE LETTERS , no.3, pp.287-291, 2008 (SCI-Expanded) Sustainable Development

178. The prevalence of dementia in an urban Turkish population

Gurvit H., Emre M., Tinaz S., Bilgic B., Hanagasi H. A., Şahin H., et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS , vol.23, no.1, pp.67-76, 2008 (SCI-Expanded)

179. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease

Dursun E., Gezen-Ak D., Eker E., Ertan T., Engin F., Hanagasi H. A., et al.

Journal of Geriatric Psychiatry and Neurology , vol.21, no.4, pp.268-273, 2008 (SCI-Expanded)

180. Subdinical impairment of neuromuscular transmission in transient global amnesia

ERTAS M., BOLAY H., Kocasoy-Orhan E., Hanagasi H. A., Baykan B.

COGNITIVE AND BEHAVIORAL NEUROLOGY , vol.20, no.3, pp.179-183, 2007 (SCI-Expanded)

181. Association between vitamin D receptor gene polymorphism and Alzheimer's disease

Gezen-Ak D., Dursun E., Ertan T., Hanagasi H. A., Guervit H., Emre M., et al.

Tohoku Journal of Experimental Medicine , vol.212, no.3, pp.275-282, 2007 (SCI-Expanded)

182. Neurosyphilis presenting with status epilepticus

Gurses C., Kurtuncu M., Jirsch J., Yesilot N., Hanagasi H. A., Bebek N., et al.

EPILEPTIC DISORDERS , vol.9, no.1, pp.51-56, 2007 (SCI-Expanded) Sustainable Development

183. The Arg 194 Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease

Dogru-Abbasoglu S., AYKAC-TOKER G., HANAGASI H. A., GURVIT H., EMRE M., UYSAL M.

Neurological Sciences , vol.28, no.1, pp.31-34, 2007 (SCI-Expanded)

184. Clinical and magnetic resonance imaging findings of HIV-Negative patients with neurosyphilis

GÜRSES C., Bilgic B., TOPÇULAR B., TUNCER O. G., AKMAN-DEMIR G., HANAGASI H. A., et al.

Journal of Neurology , vol.254, no.3, pp.368-374, 2007 (SCI-Expanded) Sustainable Development

185. Comparison of unilateral pallidotomy versus subthalamotomy in advanced idiopathic Parkinson's disease

Hanagasi H. A., Coban A., Bilgic S., Gurvit H., Yazici J., Barlas O., et al.

PARKINSONISM & RELATED DISORDERS , vol.13, 2007 (SCI-Expanded)

186. Smoking-responsive juvenile-onset parkinsonism

Hanagasi H. A., Lees A., Johnson J. O., Singleton A., Emre M.

MOVEMENT DISORDERS , vol.22, no.1, pp.115-118, 2007 (SCI-Expanded)

187. Event-related oscillations (EROs) in mesial temporal sclerosis (MTS) and Alzheimer's disease (AD)

GURVIT H., Bayraktaroglu Z., HANAGASI H. A., HANAGASI F., GOKYIGIT A. Z., DEMIRALP T.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY , vol.61, no.3, pp.299-300, 2006 (SCI-Expanded)

188. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease

Dogru-Abbasoglu S., INCEOGLU M., PARILDAR-KARPUZOGLU H., HANAGASI H. A., KARADAG B., GURVIT H., et al.

NEUROSCIENCE LETTERS , no.3, pp.258-261, 2006 (SCI-Expanded)

189. The attitude of elderly lay people towards the symptoms of dementia

SAHIN H., Gurvit I., EMRE M., Hanagasi H. A., Bilgic B., HARMANCI H.

INTERNATIONAL PSYCHOGERIATRICS , vol.18, no.2, pp.251-258, 2006 (SCI-Expanded) Sustainable Development

190. Hipoparatroidizm ve Bilateral Striopallidodentat Kalsinozis

USLU F., HANAĞASI H. A.

NOROPSIKIYATRI ARSIVI , vol.43, no.1, pp.31-36, 2006 (Peer-Reviewed Journal)

191. Parkin expression in human skeletal muscle

Serdaroglu P., Tasli H., Hanagasi H. A., Emre M.

JOURNAL OF CLINICAL NEUROSCIENCE , vol.12, no.8, pp.927-929, 2005 (SCI-Expanded)

192. Parkin expression in muscle from three patients with autosomal recessive Parkinson's disease carrying parkin mutation.

Serdaroglu P., Hanagasi H. A., Tasli H., Emre M.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology , vol.24, no.1, pp.2-5, 2005 (Scopus)

193. Unrecognized depression in community-dwelling elderly persons in Istanbul

Kulaksizoglu I., Gurvit H., Polat A., Harmanci H., Cakir S., Hanagasi H. A., et al.

INTERNATIONAL PSYCHOGERIATRICS , vol.17, no.2, pp.303-312, 2005 (SCI-Expanded)

194. Treatment of behavioural symptoms and dementia in Parkinson's disease

Hanagasi H. A., Emre M.

FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.19, no.2, pp.133-146, 2005 (SCI-Expanded)

195. Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease

Hanagasi H. A., Ayribas D., Baysal K., Emre M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.115, no.4, pp.479-493, 2005 (SCI-Expanded)

196. PARK11 is not linked with Parkinson's disease in European families

Prestel J., Sharma M., Leitner P., Zimprich A., Vaughan J., Durr A., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , vol.13, no.2, pp.193-197, 2005 (SCI-Expanded)

197. Destructive stereotactic surgery for treatment of dystonia

Murat I., Bekir O., Selhan K., Zuhal Y., Bulent O., Hasmet H. A., et al.

SURGICAL NEUROLOGY , vol.64, pp.89-95, 2005 (SCI-Expanded)

198. Periferik Travmaya Bağlı Oromandibuler Distoni

Çoban A., Hanağası H. A., Bilgiç B., Gürvit İ. H., Emre M., Yazıcı J.

Parkinson Hastalığı ve Hareket Bozuklukları Dergisi , vol.7, no.1, pp.25-28, 2004 (Peer-Reviewed Journal)

199. Obsessive-compulsive disorder secondary to bilateral frontal damage due to a closed head injury.

BİLGİÇ B., Baral-Kulaksizoglu I., Hanagasi H. A., Saylan M., Aykutlu E., GÜRVİT İ. H., et al.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology , vol.17, no.2, pp.118-20, 2004 (Scopus)

200. Clozapine Treatment in Oromandibular Dystonia

Hanagasi H. A., Bilgic B., GURVIT H., EMRE M.

Clinical Neuropharmacology , vol.27, no.2, pp.84-86, 2004 (SCI-Expanded)

201. Risk factors for Alzheimer disease: A population-based case-control study in Istanbul, Turkey

HARMANCI H., EMRE M., GURVIT H., Bilgic B., HANAGASI H. A., GUROL E., et al.

Alzheimer Disease and Associated Disorders , vol.17, no.3, pp.139-145, 2003 (SCI-Expanded) Sustainable Development

202.

Akça Kalem Ş., Öktem Tanör Ö., Hanağası H. A., Emre M.

Nöropsikiyatri Arşivi , vol.40, no.1-2, pp.13-25, 2003 (Peer-Reviewed Journal)

203. Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials

HANAGASI H. A., GURVIT I., ERMUTLU N., KAPTANOGLU G., KARAMURSEL S., IDRISOGLU H. A., et al.

COGNITIVE BRAIN RESEARCH , vol.14, no.2, pp.234-244, 2002 (SCI-Expanded)

204. Treatment of writer's cramp with botulinum toxin: Evaluation of 11 patients

Hanagasi H. A., Parman Y., Sahin H., Gurvit H., Yazici J., Emre M.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.365, 2002 (SCI-Expanded)

205. Therapeutic effects of an acetylcholinesterase inhibitor (Donepezil) on memory in Wernicke-Korsakoff's disease

Sahin H., Gurvit I., Bilgic B., Hanagasi H. A., Emre M.

CLINICAL NEUROPHARMACOLOGY , vol.25, no.1, pp.16-20, 2002 (SCI-Expanded) Sustainable Development

206. Stiff leg syndrome: Case report

Gurol M., Ertas M., Hanagasi H. A., Sahiun H., Gursoy G., Emre M.

MOVEMENT DISORDERS , vol.16, no.6, pp.1189-1193, 2001 (SCI-Expanded) Sustainable Development

207. An open letter to the Committee on the Nobel Prize in Medicine

Abbruzzese G., Agid Y., Albanese A., Alf C., Allen R., Amar K., et al.

PARKINSONISM & RELATED DISORDERS , no.2, pp.149-155, 2001 (SCI-Expanded)

208. Do unilateral ablative lesions of the subthalamic nucleu in Parkinsonian patients lead to hemiballism?

Barlas O., Hanagasi H. A., Imer M., Sahin H., Sencer S., Emre M.

MOVEMENT DISORDERS , vol.16, no.2, pp.306-310, 2001 (SCI-Expanded)

209. Intravenous apomorphine therapy in Parkinson's disease - Clinical and pharmacokinetic observations

Manson A., Hanagasi H. A., Turner K., Patsalos P., Carey P., Ratnaraj N., et al.

BRAIN , vol.124, pp.331-340, 2001 (SCI-Expanded)

210. Atypical neurological involvement associated with celiac disease

Hanagasi H. A., Gurol E., Sahin H., Emre M.

EUROPEAN JOURNAL OF NEUROLOGY , vol.8, no.1, pp.67-69, 2001 (SCI-Expanded)

211. The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa

Hanagasi H. A., Kaptanoglu G., Sahin H., Emre M.

MOVEMENT DISORDERS , vol.15, no.5, pp.1016-1017, 2000 (SCI-Expanded)

212. Neuronal intranuclear inclusion disease and juvenile parkinsonism

O'Sullivan J., Hanagasi H. A., Daniel S., Tidswell P., Davies S., Lees A.

MOVEMENT DISORDERS , vol.15, no.5, pp.990-995, 2000 (SCI-Expanded)

213. Evidence-based pharmacological treatment of dementia

Emre M., Hanagasi H. A.

EUROPEAN JOURNAL OF NEUROLOGY , vol.7, no.3, pp.247-253, 2000 (SCI-Expanded)

214. Amyotophic lateral sclerosis and frontal lobe dementia

Tüzün E., Hanağası H. A., Kaptanoğlu G., Gürvit İ. H.

TURK NOROLOJI DERGISI , vol.1, no.1, pp.67-74, 2000 (Peer-Reviewed Journal)

215. Spinoserebellar ataksi tip-2’li bir Türk ailesinde klinik ve moleküler analiz

HANAĞASI H. A., Ersoy N., BİLGİÇ B., SAHIN H., Annesi G., GÜRVİT İ. H., et al.

Parkinson Hastalığı ve Hareket Bozuklukları Dergisi , vol.1, no.1, pp.39-44, 2000 (Peer-Reviewed Journal)

216. Event-related brain potentials in amyotrophic lateral sclerosis patients

Ermutlu N., Hanagasi H. A., Kaptanoglu G., Karamursel S., Gurvit H., Idrisoglu H., et al.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY , vol.30, pp.160-161, 1998 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences 123

1. Demans ayırıcı tanısında çoklu plazma biyobelirteçlerinin rolü

Gezegen H., Alaylıoğlu M., Shoai M., Güven Z. G., Şahin E., Swann O., et al.

60.Ulusal Nöroloji Kongresi, Antalya, Turkey, 26 November - 02 December 2024, pp.200, (Summary Text)

2. Demans Hastalarında Plazma sTREM2 ve İnflamatuar Sitokin Düzeyleri Arasındaki İlişkinin İncelenmesi

Güven Z. G., Samancı B., Şahin E., Gezegen H., Ulukan Ç., Hanağası H. A., et al.

22.Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 3 - 06 September 2024, pp.296, (Summary Text)

3. Genetic characterization of a Turkish dementia cohort: a focus on leukodystrophy genes

Dehghani N., GÜVEN Z. G., Westra K., Gardner E., Paquette K., Gibbons E., et al.

Alzheimer's Association International Conference 2022, 31 July 2022, vol.18, (Summary Text)

4. Demans hastalarında plazma sTREM2 düzeyi: TREM2 varyantları ve beyin omurilik sıvısındaki amiloid ve tau düzeyleri ile ilişkisi.

Güven Z. G., Samancı B., Gezegen H., Ulukan Ç., Şahin E., Hanağası H. A., et al.

15.Ulusal Tıbbi Genetik Kongresi, Muğla, Turkey, 9 - 13 November 2022, pp.34, (Summary Text)

5. Effects of TREM2 Homozygous Mutations (Nasu-Hakola Disease) on Natural Killer Cells

Ulukan Ç., Samancı B., Hanağası H. A., Deniz G., Bilgiç B., Çetin E.

International Molecular Immunology & Immunogenetics Congress V, İzmir, Turkey, 20 - 22 October 2022, pp.42, (Summary Text)

6. Assessment of dysphagia in Idiopathic Parkinson’s disease and identifying its relationship with frailty, malnutrition, sarcopenia and quality of life

ÖZKÖK S., TÜFEKÇİOĞLU Z., BENGİSU S., BİLGİÇ B., HANAĞASI H. A., BAHAT-ÖZTÜRK G.

18th Congress of the European Geriatric Medicine Society, Londrina, Brazil, 28 - 30 September 2022, (Summary Text)

7. İdı̇yopatı̇k Parkı̇nson Hastalığında Dı̇sfajı̇ Değerlendı̇rmesı̇ ve Kırılganlık, Malnutrı̇syon, Sarkopenı̇ ve Hayat Kalı̇tesı̇ ile İlı̇şkı̇sı̇

ÖZKÖK S., TÜFEKÇİOĞLU Z., BENGİSU S., BİLGİÇ B., HANAĞASI H. A., BAHAT-ÖZTÜRK G.

4.Uluslararası 15.Geriatri Kongresi, İzmir, Turkey, 14 - 18 September 2022, (Summary Text)

8. Parkinson hastalığında yutma bozukluğu ve beyin sapı hacminin değerlendirilmesi

SAMANCI B., ŞAHİN E., TÜFEKÇİOĞLU Z., HANAĞASI H. A., GÜRVİT İ. H., ÖZKÖK S., et al.

Hareket Hastalıklarında Tanı ve Tedavide Güncel ve Gelecek Yaklaşımlar, Nevşehir, Turkey, 26 - 29 May 2022, (Summary Text)

9. İdiyopatik Parkinson Hastalığında Disfaji Değerlendirmesi ve Kırılganlık, Malnütrisyon, Sarkopeni ve Hayat Kalitesi ile İlişkisi

TÜFEKÇİOĞLU Z., ÖZKÖK S., BENGİSU S., BİLGİÇ B., BAHAT-ÖZTÜRK G., HANAĞASI H. A.

Hareket Hastalıklarında Tanı ve Tedavide Güncel ve Gelecek Yaklaşımlar, NEVŞEHİR / Kapadokya, Turkey, 26 - 29 May 2022, (Summary Text)

10. Functional movement disorder in a cerebral palsy patient

Keskin M., Polat I., Ulukan Ç., Hanağası H. A., Özkan M.

2th International Congress on Psychopharmacology &8 th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 17 - 20 November 2021, pp.219, (Summary Text)

11. WRITER'S CRAMP: A SINGLE-CENTER EXPERIENCE

Cakar A., Tufekcioglu Z., Hanagasi H., Parman Y.

TOXINS Conference on Basic Science and Clinical Aspects of Botulinum and other Neurotoxins, ELECTR NETWORK, 16 - 17 January 2021, vol.190, (Summary Text)

12. Parkinson's Disease: Do SUMO Gene Variants Play A Role in Etiopathogenesis?

Yüceer H., Küçükali C. İ., Tüzün E., Bilgiç B., Ergen H. A., Hanağası H. A.

31. Ulusal Biyokimya Kongresi, İstanbul, Turkey, 18 - 20 December 2020, pp.80, (Summary Text)

13. Analysis of copy number variation in a Turkish dementia cohort

Dehghani N., Kun-Rodrigues C., Foster K., HANAĞASI H. A., Lohmann E., GÜVEN Z. G., et al.

Alzheimer's Association International Conference (AAIC), United States Of America, 27 - 31 July 2020, vol.16, pp.44868, (Summary Text)

14. Spı̇noserebellar ataksı̇lı̇ hastalarda serebellum dışı kortı̇kal kalınlık ve volumetrı̇ analı̇zı̇

AY U., YILDIRIM Z., ERYÜREK K., DEMİRTAŞ TATLIDEDE A., BİLGİÇ B., HANAĞASI H. A., et al.

55. Ulusal Nöroloji Kongresi, 15 - 21 November 2019, (Summary Text)

15. Parkinson hastalığı için yüksek risk grubunda yer alan kişilerin klinik ve nörogörüntüleme yöntemleri ile değerlendirilmesi

Sezgin M., KIÇİK A., BİLGİÇ B., KURT E., BAYRAM A., HANAĞASI H. A., et al.

55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 - 21 November 2019, pp.48-49, (Summary Text)

16. Parkinson Hastalığı Patogenezinde Rol Alan Olası Moleküler Mekanizmalar: PI3K-Akt ve P53 Sinyal Yolakları

Karaaslan Z., Şanlı E., Timirci Kahraman Ö., Ergen H. A., Bilgiç B., Tüzün E., et al.

55.Ulusal Nöroloji Kongresi,, Antalya, Turkey, 15 - 19 November 2019, pp.78, (Summary Text)

17. Cerebrotendinous Xanthomatosis: A diagnosis not to be missed.

Odacılar Alpay A., Güneş S., Karaca M., Güneş D., Balcı M. C., Hanağası H. A., et al.

Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium, Rotterdam, Netherlands, 3 - 06 September 2019, pp.219, (Summary Text)

18. Cholesterol related gene polymorphisms in Alzheimer Disease

Güven Z. G., Vurgun E., Bilgiç B., Hanağası H. A., Gürvit İ. H., Lohmann E., et al.

European Human Genetics Conference 2018, Milan, Italy, 16 - 19 June 2018, pp.1, (Summary Text)

19. Assesment of candidate genes in patients with frontotemporal lobar degeneration spectrum: preliminary findings

Artan S., Erzurumluoglu E., Cilingir O., Adapinar B. D. O., Tepgec F., Bas H., et al.

51st Conference of the European-Society-of-Human-Genetics (ESHG) in conjunction with the European Meeting on Psychosocial Aspects of Genetics (EMPAG), Milan, Italy, 16 - 19 June 2018, vol.27, pp.277-278, (Summary Text)

20. Cholesterol related gene polymorphisms in Alzheimer Disease

Guven G., Vurgun E., Bilgic B., Hanagasi H. A., Gurvit H., Lohmann E., et al.

21. Functional magnetic resonance imaging of implicit associative learning in spinocerebellar ataxia

ULAŞOĞLU YILDIZ Ç., ERYÜREK K., DEMİRTAŞ TATLIDEDE A., BİLGİÇ B., HANAĞASI H. A., DEMİRALP T., et al.

25th Annual Meeting of the Organization for Human Brain Mapping, Italy, 9 - 13 June 2019, (Summary Text)

22. Parkinson Hastalığında SUMO Gen Variantlarının İncelenmesi

Küçükali C. İ., Yüceer H., Bilgiç B., Hanağası H. A.

54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Unpublished)

23. Frontotemporal Lobar Dejenerasyon Spektrumunda Aday Genlerin Değerlendirilmesi

ARTAN S., ERZURUMLUOĞLU E., ÖZBABALIK ADAPINAR B. D., TEPGEÇ F., ÇİLİNGİR O., BİLGİÇ B., et al.

54. Ulusal Nöroloji Kongresi, Turkey, 1 - 05 December 2018, (Summary Text)

24. TÜRK DEMANS HASTALARINDA FRONTO-TEMPORAL DEMANS İLE İLİŞKİLİ BAŞLICA GENLERDEKİ MUTASYON SIKLIĞI

Güven Z. G., Lohmann E., Bras J., Gibbs R., Gürvit İ. H., Bilgiç B., et al.

Uluslararası Katılımlı 13. Ulusal Tıbbi Genetik Kongresi, Antalya, Turkey, 7 - 11 November 2018, pp.142, (Summary Text)

25. Huntington's Disease in Turkey: A Bird's Eye Review of the Literature

Karadag Y., Akbostanci M. A., Hanagasi H. A., Oztekin N. S., Demirkiran M., Basak A. N.

International Congress of Parkinson's Disease and Movement Disorders, Hong Kong, Hong Kong, 5 - 09 October 2018, vol.33, (Summary Text)

26. Cerebrotendinous Xanthomatosis: A Rare Lipid Storage Disease

Hanagasi H. A., Yunisova G., Bilgic B., Dogu O., Kaleagasi H., Tufekcioglu Z., et al.

International Congress of Parkinson's Disease and Movement Disorders, Hong Kong, Hong Kong, 5 - 09 October 2018, (Summary Text)

27. Catatonia as clinical presentation of anti-n-methyl-d-aspartate (anti-NMDA) receptor encephalitis.

Hanağası H. A., Sezgin M., Bilgiç B., Tüfekçioğlu Z., Gürvit İ. H., Emre M.

Alzheimer’s Association International Conference, Illinois, United States Of America, 22 - 26 July 2018, pp.1467-1468, (Summary Text)

28. Assesment of candidate genes in patients with frontotemporal lobar degeneration spectrum.

ARTAN S., ERZURUMLUOĞLU E., ÇİLİNGİR O., ÖZBABALIK ADAPINAR B., TEPGEÇ F., BAŞ H., et al.

ESHG 2018, 16 - 19 June 2018, (Summary Text)

29. Assesment of candidate genes in patients with frontotemporal lobar degeneration spectrum: preliminary findings

ARTAN S., ERZURUMLUOĞLU E., ÇİLİNGİR O., ÖZBABALIK ADAPINAR B. D., TEPGEÇ F., BAŞ H., et al.

European Human Genetics Conference 2018, Milan, Italy, 16 - 19 June 2018, (Summary Text)

30. Örtük Asosiyatif Öğrenmede Serebellar Katılım: Tohum-temelli Fonksiyonel Bağlantısallık Çalışması

ULAŞOĞLU YILDIZ Ç., ERYÜREK K., KIÇİK A., KARAASLAN Z., DEMİRTAŞ TATLIDEDE A., BİLGİÇ B., et al.

16. Ulusal Sinirbilim Kongresi, Turkey, 20 May 2018, (Summary Text)

31. The relationship between resting state connectivity and episodic memory in Alzheimer’s disease

Yıldırım E., Soncu Buyukıscan E., Ulaşoğlu Yıldız Ç., Kurt E., Bilgiç B., Demirtaş Tatlıdede A., et al.

16. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 20 - 23 May 2018, vol.12, no.1, pp.45-46, (Summary Text)

32. Genetic Investigation in Parkinson Disease

TEPGEÇ F., BİLGİÇ B., TOKSOY G., DEMİRTAŞ A., TÜFEKÇİOĞLU Z., ŞAHİN İ., et al.

ERCIYES MEDICAL GENETICS DAYS, Turkey, 7 - 10 March 2018, no.1, (Summary Text)

33. Dinlenim durumu ağları ve kognitif işlevler hafif kognitif bozukluk ve sübjektif kognitif bozukluğu ayırt edebilir mi?

Soncu Buyukıscan E., Yıldırım E., KURT E., Ulaşoğlu Yıldız Ç., BİLGİÇ B., Demirtaş Tatlıdede A., et al.

53. Ulusal Nöroloji Kongresi, Antalya, Turkey, 24 - 30 November 2017, pp.61, (Full Text)

34. Differential Resting State Connectivity and Its Relationship with Cognitive Performance among Participants with Subjective Cognitive Impairment (SCI), Mild Cognitive Impairment (MCI), and Early Stage Alzheimer’s Disease (AD)

Yıldırım E., Soncu Buyukıscan E., KURT E., Ulaşoğlu Yıldız Ç., Demirtaş Tatlıdede A., BİLGİÇ B., et al.

Alzheimer's Association International Conference, Londra, United Kingdom, 16 - 20 July 2017, pp.1, (Full Text)

35. Resting state network alterations in spinocerebellar ataxia’. 23rd Annual Meeting of the Organization for Human Brain Mapping

ULAŞOĞLU YILDIZ Ç., ERYÜREK K., KARAASLAN Z., DEMİRTAŞ TATLIDEDE A., BİLGİÇ B., HANAĞASI H. A., et al.

23rd Annual Meeting of the Organization for Human Brain Mapping, Canada, 25 - 29 June 2017, (Summary Text)

36. Video-Oculography Assessment in Neurodegenerative Ataxias and Neimann Pick Type C

Hanagasi H. A., Karaarslan Z., Bilgic B., Tufekcioglu Z., Tatlidede A. D., Gurvit H., et al.

21st International Congress of Parkinson's Disease and Movement Disorders, Vancouver, Canada, 4 - 08 June 2017, (Summary Text)

37. C19orf12 p.Thr11Met mutation is frequent among adult Turkish patients with MPAN

Quadri M., Olgiati S., Dogu O., Tufekcioglu Z., Diler Y., Saka E., et al.

21st International Congress of Parkinson's Disease and Movement Disorders, Vancouver, Canada, 4 - 08 June 2017, (Summary Text)

38. The Comparison of Gait and Balance Parameters According To The Findings of Cognitive Impairment, Falling and Freezing of Gait I Patients With Parkinson Disease

ERSÖZ HÜSEYİNSİNOĞLU B., ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A., EMRE M.

Neurorehabilitation and Neural Repair, Maastricht, Netherlands, 22 May - 24 September 2017, pp.87, (Full Text)

39. Serebellum ve Örtük Bağlamsal Öğrenme

ULAŞOĞLU YILDIZ Ç., ERYÜREK K., DURU A. D., KARAASLAN Z., DEMİRTAŞ TATLIDEDE A., BİLGİÇ B., et al.

15. Ulusal Sinirbilim Kongresi, Turkey, 7 - 10 May 2017, (Summary Text)

40. Spinoserebellar Atakside Örtük Asosiyatif Öğrenme Defisiti: Bir Fonksiyonel MR Görüntüleme Çalışması

ULAŞOĞLU YILDIZ Ç., ERYÜREK K., KIÇİK A., KARAASLAN Z., DEMİRTAŞ TATLIDEDE A., BİLGİÇ B., et al.

15. Ulusal Sinirbilim Kongresi, Turkey, 7 - 10 May 2017, (Summary Text)

41. Geç ve erken başlangıçlı Alzheimer hastalığında rol oynayan miRNAların incelenmesi

Güven Z. G., Lohmann E., Hanağası H. A., Güleç Ç., Özer E., Ünaltuna N.

7.Ulusal Alzheimer Kongresi, Konya, Turkey, 20 - 23 April 2017, pp.1, (Summary Text)

42. Diffusion discriminant for mild cognitive impairment in Parkinson’s disease

Uluğ A. M., Öztürk Işık E., Kıçik A., Erdoğdu E., Cengiz S., Arslan D. B., et al.

International Society of Magnetic Resonance in Medicine Annual Conference, Honolulu, Hı, United States Of America, 22 - 27 April 2017, pp.1, (Full Text)

43. PARKİNSON HASTALARINDA NON- MOTOR BULGULAR İLE YÜRÜME VE DENGE ÖZELLİKLERİ ARASINDAKİ İLİŞKİNİN DEĞERLENDİRİLMESİ

ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A.

5. NÖROLOJİK FİZYOTERAPİ SEMPOZYUMU, İstanbul, Turkey, 13 - 14 April 2017, pp.1, (Full Text)

44. EFFECTS OF VARIOUS GRN VARIANTS ON MRNA AND SERUM PGRN LEVEL

GÜVEN Z. G., G R., ÜNALTUNA N., GÜRVİT İ. H., HANAĞASI H. A., B J., et al.

3th International Conference on Alzheimer’s and Parkinson’s Diseases, Viyana, Austria, 29 March - 02 April 2017, pp.1674, (Full Text)

45. Determination of Diffusion Weighted Magnetic Resonance Imaging Based Biomarkers of Mild Cognitive Impairment in Parkinson's Disease

Kaplan O. C., Arslan D. B., Cengiz S., Kicik A., Erdogdu E., Hatay G. H., et al.

21st National Biomedical Engineering Meeting (BIYOMUT), İstanbul, Turkey, 24 November - 26 December 2017, (Full Text)

46. Parkinson Hastalarında Yürüme ve Denge PArametrelerinin Kognisyon, Düşme ve Donma Bulgularına Göre Karşılaştırılması

ERSÖZ HÜSEYİNSİNOĞLU B., ZİREK E., TÜFEKÇİOĞLU Z., BİLGİÇ B., HANAĞASI H. A., EMRE M.

52. Ulusal Nöroloji Kongresi, Antalya, Turkey, 25 November - 01 December 2016, pp.310, (Full Text)

47. Serebellar Bulgular İle Başlayan Ailesel Alzheimer Hastalığı

Dumanlı İlki C., Tepgeç F., BİLGİÇ B., Tüfekçioğlu Z., Demirtaş Tatlıdere A., HANAĞASI H. A., et al.

52. Ulusal Nöroloji Kongresi, Antalya, Turkey, 25 November - 01 December 2016

48. GRN c.708 + 1_+4del TGAG deletion in a large family diagnosed with fronto-temporal dementia

Babacan Yıldız G., GÜVEN Z. G., HANAĞASI H. A., BİLGİÇ B., GÜRVİT İ. H., ÜNALTUNA N., et al.

10th International Conference on Frontotemporal Dementias, Münih, Germany, 31 August - 02 September 2016, vol.138, pp.323, (Summary Text)

49. GRN c.708+1_+4del TGAG deletion in a large family diagnosed with fronto-temporal dementia

Babacan-Yildiz G., Guven G., Hanagasi H. A., Bilgic B., Gurvit H., Erginel-Unaltuna N., et al.

10th International Conference on Frontotemporal Dementias, Munich, Germany, 31 August - 02 September 2016, pp.323, (Summary Text)

50. Event-related Potentials as Potential Biomarkers for Cognitive Impairment in Parkinson’s Disease

Erdoğdu E., KURT E., Büker S., BİLGİÇ B., HANAĞASI H. A., DEMİRALP T., et al.

22nd Annual Meeting of the Organization for Human Brain Mapping, Cenevre, Switzerland, 26 - 30 June 2016, pp.30, (Full Text)

51. A novel homozygous DJ1 mutation causes Parkinsonism and ALS in a Turkish family

Hanagasi H. A., Giri A., Guven G., Bilgic B., Hauser A. -., Emre M., et al.

20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 19 - 23 June 2016, (Summary Text)

52. Face and color recognition after subthalamic nucleus stimulation in Parkinson's disease

GUNDUZ A., YAGCI S., AYDIN S., Poyraz B. Ç., GENC G., OGUZ S., et al.

20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 19 - 23 June 2016, vol.31, (Summary Text)

53. Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration

Demirtas-Tatlidede A., Matur Z., Bilgic B., Hanagasi H. A., Emre M., Gurvit H., et al.

20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 19 - 23 June 2016, (Summary Text)

54. ERP-based biomarker candidates for the discrimination of mild cognitive impairment in Parkinson’s disease

Erdoğdu E., KURT E., Büker S., BİLGİÇ B., HANAĞASI H. A., DEMİRALP T., et al.

14. Ulusal Sinirbilim Kongresi, Ankara, Turkey, 26 - 29 May 2016, pp.73-74, (Full Text)

55. Differential expression of inflammatory cytokines in peripheral blood mononuclear cells in early and late onset Alzheimer‘s disease

ÜNALTUNA N., GÜVEN Z. G., Lohmann E., HANAĞASI H. A.

European Human Genetics Conference 2016, Barselona, Spain, 21 - 24 May 2016, vol.24E, pp.179, (Full Text)

56. Expression of inflammation-related miRNAs and their selected target genes in peripheral blood mononuclear cells of early and late onset Alzheimer disease patients

GÜVEN Z. G., Lohmann E., HANAĞASI H. A., GÜLEÇ Ç., ÜNALTUNA N.

European Human Genetics Conference 2016, Barselona, Spain, 21 - 24 May 2016, vol.24E, pp.180, (Full Text)

57. Anti-nöronal Otoantikor Pozitif Temporal Lop Epilepsişi Hastaların Nöropsikolojik Profillerinin Seronegatif Olgularlarla Karşılaştırılması

Sezgin M., Vanlı Yavuz E. N., Bilgiç B., Hanağası H. A., Bebek N., Gürses R. C., et al.

10. ULUSAL EPİLEPSİ KONGRESİ, İzmir, Turkey, 12 - 15 May 2016, pp.83, (Full Text)

58. A Case: Conversion Disorder with persistent movement disorder and ataxia

Karabulut S., Oflaz S., Alçalar A. N., Karbay M., Hanağası H. A.

8th International Congress on Psychopharmacology & 4th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Turkey, 20 - 24 April 2016, pp.15, (Summary Text)

59. Erken Başalayan Alzheimer Hastalığında PSEN1 ve APP Gen Mutasyonlarının Araştırılması

Tepgeç F., BİLGİÇ B., Toksoy G., Demirtaş Tatlıdere A., Tüfekçioğlu Z., HANAĞASI H. A., et al.

Uluslararası katkılı ‘Gevher Nesibe Günleri, Turkey, 11 - 13 February 2016, no.1

60. Erken Başlayan Alzheimer Hastalığında PSEN1 ve APP Gen Mutasyonlarının Araştırılması.

TEPGEÇ F., BİLGİÇ B., TOKSOY G., DEMİRTAŞ TATLIDERE A., TÜFEKÇİOĞLU Z., HANAĞASI H. A., et al.

Uluslararası katkılı ‘Gevher Nesibe Günleri 2016, Kayseri, Turkey, 11 - 13 February 2016, pp.36, (Summary Text)

61. Parkinson Hastalıgının Etyopatogenesinde Kanser Yollarının Rolü.

Yalçınkaya N., Haytural H., KÜÇÜKALİ C. İ., GÜRVİT İ. H., HANAĞASI H. A., BİLGİÇ B., et al.

7. DETAE Günleri, İstanbul, Turkey, 11 - 12 November 2015, pp.1, (Full Text) Sustainable Development

62. Clusterin polimorfizmleri ile geç başlangıçlı Alzheimer hastalığı arasındaki ilişki.

Alaylıoğlu M., GEZEN AK D., BİLGİÇ B., Eker E., DURSUN E., Gürvit H., et al.

14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, vol.1, no.1, pp.1, (Summary Text)

63. PSEN1 mutation presenting as posterior cortical atrophy

Gurvit H., Bilgic B., Hanagasi H. A., Guven G., Guerreiro R., Hardy J.

22nd World Congress of Neurology (WCN), Santiago, Chile, 31 October - 05 November 2015, vol.357, (Summary Text)

64. Compromised Regulation of Serum Cytokine Levels and BDNF Due to Low Levels of Vitamin D in Patients with Early or Late Onset Alzheimer’s Disease or Parkinson’s Disease.

GEZEN AK D., BİLGİÇ B., HANAĞASI H. A., ERTAN F. S., LOHMANN E., ATASOY I. L., et al.

Alzheimer’s Association International Conference (AAIC 2015), 17-23 July, 2015 Washington, USA, Washington, United States Of America, 17 - 23 July 2015, pp.1-2, (Summary Text)

65. Association Between Clusterin Polymorphisms and Alzheimer’s Disease.

Alaylıoğlu M., GEZEN AK D., DURSUN E., HANAĞASI H. A., BİLGİÇ B., GÜRVİT İ. H., et al.

Alzheimer’s Association International Conference (AAIC 2015), 17-23 July, 2015 Washington, USA, Washington, United States Of America, 17 - 23 July 2015, pp.1, (Full Text)

66. Adult onset phenylketonuria with rapidly progressive dementia and Parkinsonism

Tufekcioglu Z., Cakar A., Bilgic B., Hanagasi H. A., Gurvit H. I., Emre M.

19th International Congress of Parkinson's Disease and Movement Disorders, California, United States Of America, 14 - 18 June 2015, vol.30, (Summary Text)

67. Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation

Hanagasi H. A., Bilgic B., Abbink T. E. M., Hanagasi F., Tufekcioglu Z., Gurvit H., et al.

19th International Congress of Parkinson's Disease and Movement Disorders, California, United States Of America, 14 - 18 June 2015, vol.30, (Summary Text)

68. Anti-NMDA receptor encephalitis with cancer of unknown primary origin

Tuzun E., Coban A., Turkoglu R., Bilgic B., Hanagasi H. A., Gurvit H.

1st Congress of the European-Academy-of-Neurology, Berlin, Germany, 20 - 23 June 2015, vol.22, pp.526, (Summary Text) Sustainable Development

69. Wernicke-Korsakoff sendromunda kognitif semptomlar için repetitif transkranial manyetik stimülasyon: Olgu sunumu

DEMİRTAŞ TATLIDEDE A., ÖGE A. E., ULAŞOĞLU YILDIZ Ç., İŞCEN P., HANAĞASI H. A., BİLGİÇ B., et al.

5. Ulusal Alzheimer Kongresi, Turkey, 2 - 05 April 2015, (Summary Text)

70. Geç ve erken başlangıçlı Alzheimer hastalığında rol oynayan miRNAların incelenmesi

Güven Z. G., Lohmann E., Hanağası H. A., Ünaltuna N.

DETAE Genç Araştırıcılar Toplantısı, İstanbul, Turkey, 19 - 20 January 2015, pp.8, (Summary Text)

71. Alzheimer hasta grubunda CLU rs11136000C>T polimorfizminin incelenmesi

Özer E., Güven Z. G., Lohmann E., Emre M., Hanağası H. A., Gürvit İ. H., et al.

6.DETAE Günleri, İstanbul, Turkey, 24 - 25 November 2014, pp.1, (Summary Text)

72. Anti nöronal Antikora Sahip Hastaları Prognozu

ÇELİK Ş., TÜZÜN E., DEMİR G., ÇOBAN A., İÇÖZ S., BİRDAY E., et al.

50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014

73. Evaluation of Incidence and Clinical Features of Antibody Associated Autoimmune Encephalitis Mimicking Dementia.

Erdağ E., ÇOBAN A., KÜÇÜKALİ C. İ., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., et al.

Alzheimer’ s Association International Conference, Copenhagen, Denmark, 12 - 17 July 2014, pp.1, (Full Text)

74. Electrophysiological measures as potential biomarkers for cognitive impairment in Parkinson’s disease

Erdoğdu E., KURT E., Büker S., Tüfekçioğlu Z., BİLGİÇ B., HANAĞASI H. A., et al.

1st Joint Turkish-German Symposium on Human Neuroscience, Berlin, Germany, 5 - 07 June 2014, pp.26-27, (Full Text)

75. Demansı Taklit Eden Antikor Iliskili Otoimmün Ensefalitin Insidansının ve Klinik Özelliklerinin Degerlendirilmesi.

Erdağ E., KÜÇÜKALİ C. İ., TÜZÜN E., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H.

12. Ulusal Sinirbilimleri Kongresi, İstanbul, Turkey, 28 - 31 May 2014, pp.1, (Full Text)

76. The distinct genetic pattern of ALS in Turkey

Ozoguz A., Uyan O., Birdal G., Iskender C., Omur O., Lahut S., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.261, (Summary Text)

77. The distinct genetic pattern of ALS in Turkey

Ozoguz A., Uyan O., Birdal G., Iskender C., Omur O., Lahut S., et al.

Joint Congress of European Neurology, İstanbul, Turkey, 31 May - 03 June 2014, vol.21, pp.63, (Summary Text)

78. Testing of diagnostic criteria for mild cognitive impairment in patients with Parkinson's disease

Hanagasi H. A., Uysal-Canturk P., Bilgic B., Gurvit H., Emre M.

18th International Congress of Parkinson's Disease and Movement Disorders, Stockholm, Sweden, 8 - 12 June 2014, vol.29, (Summary Text)

79. Neuroacanthocytosis: A case report

Yigiter R., Elci M. A., Hanagasi H. A.

18th International Congress of Parkinson's Disease and Movement Disorders, Stockholm, Sweden, 8 - 12 June 2014, vol.29

80. Evaluation of incidence and clinical features of antibody associated autoimmune encephalitis mimicking dementi

ERDAĞ E., ÇOBAN A., KÜÇÜKALİ C., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., et al.

Alzheimer’s Association International Conference, 12 July 2014

81. Serum complement factor H levels in late onset Alzheimer's disease

Yilmazer S., Gezen-Ak D., Dursun E., Hanagasi H. A., Bilgic B., Lohman E., et al.

38th Congress of the Federation-of-European-Biochemical-Societies (FEBS), Saint Peter, Guernsey And Alderney, 6 - 11 July 2013, vol.280, pp.430, (Summary Text)

82. Investigation of SORL1 variants in a Turkish cohort of dementia patients

Güven Z. G., Guerreiro R., Lohmann E., Bras J., Gibbs R., Singleton A., et al.

European Society of Human Genetics Congress, Paris, France, 8 - 11 June 2013, vol.21, pp.219, (Summary Text)

83. Geç başlangıçlı Alzheimer hasta grubunda SORL1 c.5239+73C>T polimorfizminin incelenmesi

GÜVEN Z. G., Lohmann E., EMRE M., HANAĞASI H. A., GÜRVİT İ. H., BİLGİÇ B., et al.

10. Ulusal Tıbbi Genetik Kongresi, Bursa, Turkey, 20 December 2012, (Summary Text)

84. Geç başlangıçlı Alzheimer hasta grubunda SORL1 c.5239+73C>T polimorfizminin incelenmesi

Güven Z. G., Lohmann E., Emre M., Hanağası H. A., Gürvit İ. H., Bilgiç B., et al.

10. Ulusal Tıbbi Genetik Kongresi, Bursa, Turkey, 20 - 23 December 2012, pp.1, (Summary Text)

85. Botulinum Toksini Yüz Bölgesi Uygulamaları

MATUR Z., ÇOBAN A., HANAĞASI H. A., PARMAN F. Y.

8. Ulusal Parkinson Ve Hareket Bozuklukları Kongresi, Turkey, 30 September 2009

86. Botulinum Toksini Yüz Bölgesi Uygulamaları

MATUR Z., ÇOBAN A., HANAĞASI H. A., PARMAN F. Y.

45. Ulusal Nöroloji Kongresi, Turkey, 10 November 2009

87. Botulinum Toxin Injections For The Facial Region

Matur Z., ÇOBAN A., Babacan G., Shugaiv E., HANAĞASI H. A., PARMAN F. Y.

Twentieth Meeting of the European Neurological Society, 19 June 2010

88. Üst Ve Alt Ekstremite Spastisitesinde Ardışık Botulinum Toksini Tip A Kullanımının Sonuçları

ÇOBAN A., MATUR Z., HANAĞASI H. A., PARMAN F. Y.

47. Ulusal Nöroloji Kongresi, Turkey, 25 November 2011

89. Comparative analysis of event-related potentials and oscillations during auditory oddball task in parkinson’s patients with parkin gene mutations and idiopathic parkinson’s disease

Uslu A., Demirci H., Hanağası H. A., Ergen M., Demiralp T.

XIth International Conference on Cognitive Neuroscience (ICON XI), Palma, Spain, 25 - 29 September 2011, pp.104, (Summary Text)

90. Evaluation of cognitive deficits in patients with parkin (PARK2) gene mutations using auditory event-related potentials

Uslu A., Ergen M., Demirci H., Lohmann E., Hanağası H. A., Demiralp T.

Turkish Society of Physiological Sciences and The Federation of European Physiological Societies (FEPS), Turkish-FEPS Physiology Congress, İstanbul, Turkey, 3 - 07 September 2011, vol.203, no.686, pp.137, (Full Text)

91. THE EFFECTS OF RASAGILINE ON COGNITIVE DEFICITS IN PARKINSON'S DISEASE PATIENTS WITHOUT DEMENTIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY

HANAĞASI H. A., Gurvit H., Unsalan P., Horozoglu H., Tuncer N., FEYZİOĞLU A., et al.

15th Congress of the European-Federation-of-Neurological-Societies (EFNS), Budapest, Hungary, 10 - 13 September 2011, vol.18, pp.247, (Summary Text)

92. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multi-center study

HANAGASI H. A., Gurvit H., UNSALAN P., HOROZOGLU H., TUNCER N., FEYZIOGLU A., et al.

15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, Canada, 01 January 2011, vol.26, (Summary Text)

93. Parkin (PARK2) gen mutasyonu bulunan ve bulunmayan parkinson hastalarında olaya ilişkin osilasyon bulguları, Event-related oscillations findings in parkinson’s patients with and without parkin (PARK2) gene mutations. S14

Uslu A., Ergen M., Demirci H., Hanağası H. A., Demiralp T.

10. Ulusal Sinirbilim Kongresi, İstanbul, Turkey, 9 - 12 April 2011, vol.1, no.1, pp.70, (Summary Text)

94. Event-related potentials and oscillations during oddball task in parkinson patients with PARK2 gene mutations

Uslu A., Ergen M., Demirci H., Hanağası H. A., Demiralp T.

7th Annual ECNS / ISNIP Conference, (ECNS) EEG & Clinical Neuroscience Society, (ISBET) lnternational Society for Brain Electromagnetic Topography, (lSNlP) lnternational Society for Neuroimaging in Psychiatry Joint Meeting., İstanbul, Turkey, 14 - 18 September 2010, vol.41, no.4, pp.46, (Full Text)

95. Botulinum toxin injections for the facial region

Matur Z., Coban A., Babacan G., Shugaiv E., Hanagasi H. A., Parman Y.

20th Meeting of the European-Neurological-Society, Berlin, Germany, 19 - 23 June 2010, vol.257, (Summary Text)

96. Assessment of Cognitive Dysfunction in Parkinson Patients with Parkin Mutations by Neurophysiological Tests

Demirci H., Uslu A., Lohmann E., Hanağası H. A., Demiralp T.

Cognitive VII, International Cognitive Neuroscience Meeting, İstanbul, Turkey, 18 - 20 May 2010, vol.4, no.2, pp.41-43, (Full Text)

97. Event-related potential (ERP) correlates of cognitive dysfunction in parkinson patients with parkin mutations

Uslu A., Demirci H., Keskin Ergen Y., Lohmann E., Hanağası H. A., Demiralp T.

Cognitive VII, International Cognitive Neuroscience Meeting, İstanbul, Turkey, 18 - 20 May 2010, vol.4, no.2, pp.33-34, (Full Text)

98.

Uslu A., Demirci H., Lohmann E., Hanağası H. A., Demiralp T.

9th National Congress of Neuroscience. , İstanbul, Turkey, 13 - 17 April 2010, vol.16, pp.212, (Summary Text)

99. Esansiyel Tremor Parkinson Hastalığı İçin Bir Risk Midir

YILDIZ G., ÇOBAN A., HANAĞASI H. A., YAZICI J., EMRE M., GÜRVİT İ. H.

8. Ulusal Parkinson ve Hareket Bozuklukları Kongresi, Turkey, 30 September 2009

100. İleri Evre İdiopatik Parkinson Hastalığında Unilateral Pallidotomi ve Subtalamotomi Sonuçlarının Karşılaştırılması

GÖKER B., ÇOBAN A., BİLGİÇ S., HANAĞASI H. A., KARADERELER S., BARLAS O.

Türk Nöroşirurji Derneği XXI. Bilimsel kongresi, Turkey, 20 April 2007

101. Autosomal-recessive gene mutation frequencies in Turkish patients with Parkinson's disease

DURSUN B., LOHMANN E., LESAGE S., HANAGASI H. A., AYDIN O., BABACA G., et al.

13th International Congress of Parkinsons Disease and Movement Disorders, Paris, France, 7 - 11 June 2009, vol.24, (Summary Text)

102. Polymorphisms in the DNA Repair Genes HOGG1 and APE1 and the risk of alzheimer diseaseAlzheimer's Association lnternational Conference on Alzheimer's Disease July 26-31, 2008 Chicago, lllinois

HANAĞASI H. A., KARPUZOĞLU F. H., ABBASOĞLU S., KARADAĞ B., GÜRVİT İ. H., EMRE M., et al.

Alzheimer's and Dementia the journal of the alzheimers association, Chicago, United States Of America, 26 July 2008, vol.4, pp.587, (Summary Text)

103. Anti-neuronal antibodies in Hashimoto's thyroiditis patients with central nervous system involvement

Durmuş H., Icoez S., Tuezuen E., Kuertuencue M., Hanagasi H. A., Bebek N., et al.

18th Meeting of the European-Neurological-Society, Nice, France, 7 - 11 June 2008, pp.139, (Summary Text)

104. Ataxia with vitamin E deficiency in Turkey

Hanagasi H. A., Castellotti B., Mariotti C., Gellera C., Gurvit H., Yazici J., et al.

12th International Congress of Parkinsons Disease and Movement Disorders, Illinois, United States Of America, 22 - 26 June 2008, vol.23, (Summary Text)

105. Comparison of unilateral pallidotomy versus subthalamotomy in advanced idiopathic Parkinson’s disease

Hanağası H. A., Çoban A., Bilgiç S., Gürvit İ. H., Yazıcı J., Barlas O., et al.

XVIIth WFN World Congress on Parkinson’s Disease and Related Disorders, , Amsterdam, Netherlands, 9 - 13 December 2007, vol.13, no.2, pp.172-173, (Summary Text)

106. . The Reliability and Validity Studies of the Turkish Form of Frontal Systems Behavior Scale (FrSBe).

Akça Kalem Ş., Gürvit İ. H., Hanağası H. A., Çoban A., Akman Demir G.

International Cognitive Neuroscience Symposium, Muğla, Turkey, 16 - 20 May 2007, vol.2, no.2, pp.115, (Summary Text)

107. Clinical aspects of L-2-HGA disease in 13 Turkish children

Yapici Z., Alpay K., Yalcin D., Hanagasi H. A., Eraksoy M.

17th Meeting of the European-Neurological-Society, Rhodes, Greece, 16 - 20 June 2007, vol.254, pp.97-98

108. Efficiency of botulinum toxin in treatment of writer's cramp: Long-term follow-up results

Matur Z., Hanagasi H. A., Parman Y.

11th International Congress of Parkinsons Disease and Movement Disorders, İstanbul, Turkey, 3 - 07 June 2007, vol.22

109. Retrospective cross-over evaluation of two botulinum toxin type A preparations (Botox (R) and Dysport (R)) in the treatment of lower limb spasticity

Parman Y., Hanagasi H. A., Topcular B.

11th International Congress of Parkinsons Disease and Movement Disorders, İstanbul, Turkey, 3 - 07 June 2007, vol.22

110. Retrospective cross-over evaluation of two botulinum toxin type A preparations (Botox (R) and Dysport (R)) in the treatment of upper limb spasticity

Parman Y., Hanagasi H. A., Topcular B.

11th International Congress of Parkinsons Disease and Movement Disorders, İstanbul, Turkey, 3 - 07 June 2007, vol.22

111. Parkin immunolocalization in target fibers

Yilmazer S., Tasli H., Hanagasi H. A., Emre M., Serdaroglu P.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16

112. SNPs at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease.

GEZEN AK D., DURSUN E., ERTAN T., HANAĞASI H. A., Gürvit H., Emre M., et al.

10th International Conference on Alzheimer’s Disease and Related Disorders,, Spain, vol.2, no.3, pp.195-0, (Full Text)

113. Neurosyphilis presenting status epilepticus: Two HIV (-) patients with EEG features

Gurses C., Kurtuncu M., Yesilot N., Hanagasi H. A., Bebek N., Baykan B., et al.

18th World Congress of Neurology, Sydney, Australia, 5 - 11 November 2005, vol.238, (Summary Text) Sustainable Development

114. Polymorphisms at the Ligand Binding Sites of Vitamin D Receptor Gene and Alzheimer’s Disease

GEZEN AK D., DURSUN E., ERTAN T., HANAĞASI H. A., Gürvit H., Emre M., et al.

21st International Conference of Alzheimer’s Disease International, Turkey, pp.50, (Full Text)

115. Geç Başlangıçlı Ornitin Transkarbamilaz Eksikliği Bir Olgu Sunumu

ÇOBAN A., GÜRSES R. C., HANAĞASI H. A., BAYKAL B., EMRE M., GÖKYİĞİT A.

4. Ulusal Epilepsi Kongresi, Turkey, 09 June 2004

116. Auditory evoked N100 and P200 potantials in Alzeheimer’s disease

USLU A., ERGEN M., BİLGİÇ B., HANAĞASI H. A., GÜRVİT İ. H., EMRE M., et al.

4th National Congress of Neuroscience, Mersin, Turkey, 29 March - 02 April 2005, vol.4, no.1, pp.8, (Full Text)

117. Pain in Parkinson's disease

Hanagasi H. A., Akat S., Gurvit H., Emre M., Yazici J.

9th International Congress of Parkinsons Disease and Movement Disorders, Louisiana, United States Of America, 5 - 08 March 2005, vol.20, (Summary Text)

118. Two HIV (-) patients with neurosyphilis presenting convulsive and nonconvulsive status epilepticus in different stages of their disease

GURSES C., KURTUNCU M., Yesilot N., HANAGASI H. A., BEBEK N., BAYKAN B., et al.

26th International Epilepsy Congress, Paris, France, 28 August - 01 September 2005, vol.46, pp.147, (Summary Text) Sustainable Development

119. Presenilin-1 gene intronic polymorphism in late-onset Alzheimer's disease

Dursun E., Gezen-Ak D., Eker E., Ertan T., Engin F., Hanagasi H. A., et al.

9th International Conference on Alzheimers Disease and Related Disorders, Pennsylvania, United States Of America, 17 - 22 July 2004, vol.25, (Summary Text)